Author

I. Garajova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Aigelsreiter· 1 shared A. Ardizzoni· 1 shared A. Botto· 1 shared A. D'Errico· 1 shared A. Gregori· 1 shared A. J. M. Zweemer· 1 shared B. van de Water· 1 shared C. Bergonzini· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Aigelsreiter

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells

C. Bergonzini, A. Gregori, T. M. S. Hagens, V. E. van der Noord, B. van de Water, A. J. M. Zweemer, M. Capula, G. Mantini, A. Botto, F. Finamore, I. Garajova, L. A. McDonnell, T. Schmidt, E. Giovannetti, E. H. J. Danen

This study identifies ABCB1 overexpression via locus amplification as a conserved mechanism of paclitaxel resistance in PDAC and shows that targeting ABCB1 can sensitize resistant cells to treatment.

bioRxiv · May 30, 2023 · PreprintCancer Biology

Molecular diagnosis and prognosis of cancers of unknown-primary (CUPs): progress from a microRNA-based droplet digital PCR assay

N. Laprovitera, M. Riefolo, E. Porcellini, G. Durante, I. Garajova, F. Vasuri, A. Aigelsreiter, N. Dandachi, G. Benvenuto, F. Agostinis, S. Sabbioni, I. Berindan-Neagoe, C. Romualdi, A. Ardizzoni, D. Trere, , M. Ferracin

This study uses a microRNA-based droplet digital PCR assay to identify the tissue-of-origin and predict prognosis in cancers of unknown primary (CUPs).

bioRxiv · Feb 3, 2021Pathology